Apicomplexan cyclophilins in host-parasite interaction and their potential as anti-parasitic drug targets

Molecular and Cellular Pharmacology

Volumn 4, Issue 3, 2012, Pages 105-115

  Ibrahim, Hany M ^a   Nishikawa, Yoshifumi ^b  

^a Menoufia University   (Egypt)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Apicomplexa; Cyclophilin; Cyclosporin; Neospora; Plasmodium; Toxoplasma

Indexed keywords

CALCINEURIN; CYCLOPHILIN; CYCLOSPORIN A; FK 506 BINDING PROTEIN; GAMMA INTERFERON; IMMUNOPHILIN; INTERLEUKIN 12; PROFILIN;

ANTIMICROBIAL ACTIVITY; APICOMPLEXA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; DRUG TARGETING; HOST PARASITE INTERACTION; HUMAN; LYMPHOCYTE PROLIFERATION; MACROPHAGE MIGRATION; NEOSPORA CANINUM; NONHUMAN; PARASITOSIS; PLASMODIUM FALCIPARUM; PROTEIN FOLDING; REVIEW; SEQUENCE HOMOLOGY; TOXOPLASMA GONDII;

ANIMALIA; APICOMPLEXA; NEOSPORA; PLASMODIUM (APICOMPLEXA); PROTOZOA; TOXOPLASMA;

EID: 84871859218     PISSN: None     EISSN: 19381247     Source Type: Journal    
DOI: 10.4255/mcpharmacol.12.12     Document Type: Review

References (89)

1. Dubey JP. Toxoplasmosis. J Am Vet Med Assoc 1994;205:1593-98.
2. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992;15:211-22.
3. Bowie WR, King AS, Werker DH. et al. Outbreak of toxoplasmosis associated with municipal drinking water. Lancet 1997;350:173-7.
4. Cox-Singh J, Davis TM, Lee KS. et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin Infect Dis 2008;46:165-71.
5. Manguin S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T. Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect Genet Evol 2010;10:159-77.
6. Anderson ML, Blanchard PC, Barr BC. et al. Neospora-like protozoan infection as a major cause of abortion in California dairy cattle. J Am Vet Med Assoc 1991;198:241-4.
7. Barber JS, Trees AJ. Clinical aspects of 27 cases of neosporosis in dogs. Vet Rec 1996;139:439-43.
8. Dubey JP. Review of Neospora caninum and neosporosis in animals, Korean J Parasitol 2003;41:1-16.
9. Kim K, Weiss LM. Toxoplasma gondii: the model apicomplexan. Int J Parasitol 2004;34:423-32.
10. Fischer G, Aumüller T. Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes. Rev Physiol Biochem Pharmacol 2003;148:105-50.
11. Bell A, Monaghan P, Page AP. Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action. Int J Parasitol 2006;36:261-76.
12. Krücken J, Greif G, von Samson-Himmelstjerna G. In silico analysis of the cyclophilin repertoire of apicomplexan parasites. Parasit Vectors 2009; 2:27.
13. Hacker J, Fischer G. Immunophilins: structure-1 function relationship and possible role in microbial pathogenicity. Mol Microbiol 1993;10:445-56.
14. Bell A, Roberts HC, Chappell LH. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications. Gen Pharmacol 1996;27:963-71.
15. Hirtzlin J, Farber PM, Franklin RM, Bell A. Molecular and biochemical characterization of a Plasmodium falciparum cyclophilin containing a cleavable signal sequence. Eur J Biochem 1995;232:765-72.
16. Berriman M, Fairlamb AH. Detailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparum. Biochem J 1998;334:437-45.
17. Reddy GR. Cloning and characterization of a Plasmodium falciparum cyclophilin gene that is stage-specifically expressed. Mol Biochem Parasitol 1995;73:111-21.
18. Carlton JM, Angiuoli SV, Suh BB, et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002;419:512-19.
19. Hall N. Karras M, Raine JD, et al. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic and proteomic analyses. Science 2005;307:82-6.
20. Cui L, Fan Q, Hu Y, et al. Gene discovery in Plasmodium vivax through sequencing of ESTs from mixed blood stages. Mol Biochem Parasitol 2005;144:1-9.
21. Bozdech Z, Llinas M, Pulliam BL, et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biol 2003;1: E5.
22. Le Roch KG, Zhou Y, Blair PL, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 2003;301:1503-8.
23. Gavigan CS, Kiely SP, Hirtzlin J, Bell A. Cyclosporin-binding proteins of Plasmodium falciparum. Int J Parasitol 2003;33:987-96.
24. Dobson S, May T, Berriman M, et al. Characterization of protein Ser/Thr phosphatases of the malaria parasite, Plasmodium falciparum: inhibition of the parasitic calcineurin by cyclophilin-cyclosporin complex. Mol Biochem Parasitol 1999;99:167-81.
25. Kumar R, Musiyenko A, Barik S. Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin. Mol Biochem Parasitol 2005;141: 29-37.
26. Gavigan CS, Bell A. A role for Pgh1 in the mechanism of antimalarial action of cyclosporins on Plasmodium falciparum. Exp Parasitol 2003;105:41.
27. Kumar R, Musiyenko A, Oldenburg A, et al. Post translational generation of constitutively active cores from larger phosphatases in the malaria parasite, Plasmodium falciparum: implications for proteomics. BMC Mol Biol 2004;5: 6.
28. Marín-Menéndez A, Bell A. Over expression, purification and assessment of cyclosporin binding of a family of cyclophilins andcyclophilin-like proteins of the human malarial parasite Plasmodium falciparum. Protein Expr Purif 2011; 78:225-34.
29. Denkers EY. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 2003; 39:193-203.
30. Cai G, Kastelein R, Hunter CA. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun 2000;68:6932-8.
31. Cai G, Radzanowski T, Villegas EN, et al. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol 2000;165:2619-27.
32. Gazzinelli RT, Hieny S, Wynn TA, et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA. 1993;90:6115-9.
33. Hunter CA, Subauste CS, Van Cleave VH, Remington JS. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 1994;62:2818-24.
34. Aliberti J, Valenzuela JG, Carruthers VB, et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol 2003;4:485-90.
35. High KP, Joiner KA, Handschumacher RE. Isolation, cDNA sequences, and biochemical characterization of the major cyclosporin-binding proteins of Toxoplasma gondii. J Biol Chem 1994;269:9105-12.
36. Silverman JA, Hayes ML, Luft BJ, Joiner KA. Characterization of anti- Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology. Antimicrob Agents Chemother 1997;41:1859-66.
37. Ibrahim HM, Bannai H, Xuan X, Nishikawa Y. Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces Bradyzoite conversion in a CCR5-dependent manner. Infect Immun 2009;77:3686-95.
38. Yarovinsky F, Andersen JF, King LR, et al. Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii. J Biol Chem 2004;279:53635-42.
39. Aliberti J, Reis e Sousa C, Schito M, et al. CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha+ dendritic cells. Nat Immunol. 2000;1:83-7.
40. Ibrahim HM, Xuan X, Nishikawa Y. Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells. Clin Vaccine Immunol 2010;17:1322-9.
41. Sànchez-Tilló E, Wojciechowska M, Comalada M, et al. Cyclophilin A is required for M-CSF-dependent macrophage proliferation. Eur J Immunol 2006;36:2515-24.
42. Denkers EY, Caspar P, Sher A. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes. J Exp Med 1994;180:985-94.
43. Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998;11:569-88.
44. Subauste CS, Fuh F, de Waal Malefyt R, Remington JS. Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals. J Immunol 1998;160:3403-11.
45. Aosai F, Chen M, Kang HK, et al. Toxoplasma gondii-derived heat shock protein HSP70 functions as a B cell mitogen. Cell Stress Chaperones 2002;7:357-64.
46. Yang G, Hellstrom K, Hellstrom I, Chen L. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J Immunol 1995;154:2794-800.
47. Camp RL, Scheynius A, Johansson C, Puré E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 1993;178:497-507.
48. Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993;54:271-335.
49. Clark RA, Alon R, Springer TA. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J Cell Biol 1996;134:1075-87.
50. Ariel A, Lider O, Brill A, et al. Induction of interactions between CD44 and hyaluronic acid by a short exposure of human T cells to diverse pro-inflammatory mediators. Immunology 2000;100:345-51.
51. DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997;278:672-5.
52. Estess P, DeGrendele HC, Pascual V, Siegelman MH. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity. J Clin Invest 1998;102:1173-82.
53. Diana J, Vincent C, Peyron F, et al. Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clin Exp Immunol 2005;141:475-84.
54. Sher A, Hieny S, Charest H, et al. The role of dendritic cells in the initiation of host resistance to Toxoplasma gondii. Adv Exp Med Biol 1998;452:103-10.
55. Lambert H, Hitziger N, Dellacasa I, et al. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol 2006;8:1611-23.
56. Luangsay S, Kasper LH, Rachinel N, et al. CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology 2003;125:491-500.
57. Hunter CA, Roberts CW, Alexander J. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis. Eur J Immunol 1992;22:2317-22.
58. Hunter CA, Roberts CW, Murray M, Alexander J. Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis. Parasite Immunol 1992;14:405-13.
59. Scanga CA, Aliberti J, Jankovic D. et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol 2002;168:5997-6001.
60. Yarovinsky F, Zhang D, Andersen JF. et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005;308:1626-9.
61. Plattner F, Yarovinsky F, Romero S. et al. Toxoplasma profilin is essential for host cell invasion and TLR11-dependent induction of an interleukin-12 response. Cell Host Microbe 2008;3:77-87.
62. Mun HS, Aosai F, Norose K, et al. Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect Immun 2005;73:4634-42.
63. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 1988;240:516-8.
64. Suzuki Y, Conley FK, Remington JS. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect Immun 1990;58:3050-5.
65. Gazzinelli RT, Hakim FT, Hieny S, et al. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 1991;146:286-92.
66. Scharton-Kersten TM, Wynn TA, Denkers EY, et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J Immunol 1996;157:4045-54.
67. James SL. Role of nitric oxide in parasitic infections. Microbiol Rev 1995;59:533-47.
68. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998;11:267-99.
69. Bohne W, Heesemann J, Gross U. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun 1994;62:1761-7.
70. Liew FY, Cox FEG. Nonspecific defense mechanism: the role of nitric oxide. Immunol Today 1991;12:A17-A21.
71. Sibley LD, Adams LB, Fukotomi Y, Krahenbuhl JL. Tumor necrosis factor alpha triggers anti-Toxoplasmal activity of IFN-gamma primed macrophages. J Immunol 1991;147:2340-5.
72. Langermans JAM, van der Hulst MEB, Nibbering PH, et al. IFN-γ induced L-arginine dependent Toxoplasma static activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor alpha. J Immunol 1992;148:568-74.
73. Nishikawa Y, Xuenan X, Makala L, et al. Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. Int J Parasitol 2003;33:1525-35.
74. Drapier JC, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial ironsulfur enzymes in the macrophage effector cells. J Immunol 1988;140:2829-2838.
75. Kolb H, Kolb-Bachofen V. Nitric oxide: a pathogenetic factor in autoimmunity. Immunol Today 1992;13:157-160.
76. Soête M, Dubremetz JF. Toxoplasma gondii: kinetics of stage-specific protein expression during tachyzoite-bradyzoite conversion in vitro. Curr Top Microbiol Immunol 1996;219:76-80.
77. Tomavo S, Boothroyd JC. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii. Int J Parasitol 1995;25:1293-9.
78. Vercesi AE, Rodrigues CO, Uyemura SA, et al. Respiration and oxidative phosphorylation in the apicomplexan parasite Toxoplasma gondii. J Biol Chem 1998;273:31040-7.
79. Persson EK, Agnarson AM, Lambert H, et al. Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol 2007;179:8357-65.
80. Tuo W, Fetterer R, Jenkins M, Dubey JP. Identification and characterization of Neospora caninum cyclophilin that elicits gamma interferon production. Infect Immun 2005;73:5093-100.
81. Kameyama K, Nishimura M, Punsantsogvoo M, et al. Immunological characterization of Neospora caninum cyclophilin. Parasitology 2012;139:294-301.
82. Mineo TW, Oliveira CJ, Silva DA, et al. Neospora caninum excreted/secreted antigens trigger CC-chemokine receptor 5-dependent cell migration. Int J Parasitol 2010;40:797-805.
83. Tuo W, Zhao Y, Zhu D, Jenkins MC. Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum. Vaccine 2011;29:2392-9.
84. Thommen-Scott K. Antimalarial activity of cyclosporin A. Agents and actions 1981;11:770-3.
85. Lillehoj HS. Effects of immunosuppression on avian coccidiosis: cyclosporin A but not hormonal bursectomy abrogates host protective immunity. Infect Immun 1987;55:1616-21.
86. Rose ME, Hesketh P. Eimeria vermiformis and E. mitis: inhibition of development in vivo by cyclosporin A. Exp Parasitol 1989;68:289-296.
87. Perkins ME, Wu TW, Le Blancq SM. Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum. Antimicrob Agents Chemother 1998;42:843-8.
88. Ahmed JS, Rintelen M, Hartwig H, Schein E. Effect of cyclosporin A on the proliferation of bovine lymphocytes to concanavalin A and on the growth of Theileria annulata-infected bovine cells. Trop Med Parasitol 1991;42:375-80.
89. Hosse RJ, Krücken J, Bierbaum S, et al. Eimeria tenella: genomic organization and expression of an 89 kDa cyclophilin. Exp Parasitol 2008;118:275-9.